secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2022-04-01T23:59:59+00:00
Accession:  0001493152-22-008865
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics adopts amended bylaws; permits classified board, eliminates written consent
--------------------------------------------------------------------------------

- Board adopted amended and restated bylaws effective March 31, 2022.
- New bylaws permit creation of a classified board of directors.
- Quorum requirement for stockholder meetings reduced; detailed requirements for shareholder proposals and board nominations added.
- Shareholder action by written consent eliminated; indemnification of officers and directors allowed.
- Full text of amended bylaws filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315222008865/0001493152-22-008865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315222008865/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-008865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer